[1] McManus IR,Contag AO,Olson RE. Characterization of endogenous ethanol in the Mamml. Science,1960,131(3393):102-103. [2] Volynets V,Kuper MA,Strahl S,et al. Nutrition,intestinal permeability,and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease(NAFLD). Dig Dis Sci,2012,57(7):1932-1941. [3] Zhu L,Baker SS,Gill C,et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients:a connection between endogenous alcohol and NSH. Hepatology,2013,57(2):601-609. [4] Cope K,Risby T,Diehl A M. Increased gastrointestinal ethanol production in obese mice:implications for fatty liver disease pathogenesis. Gastoenterology,2000,119(5):1340-1347. [5] 范建高,徐正婕,王国良,等. 大鼠NASH形成过程血清内毒素含量的改变. 中华肝脏病杂志,2003,11(2):73-76 [6] 徐正婕, 范建高,王国良,等. 小剂量内毒素导致非酒精性脂肪性肝炎大鼠急性肝功能衰竭. 中华肝脏病杂志,2004,12(4): 244-245. [7] 李楠,徐正婕,范建高,等. 口服抗生素对NASH大鼠肝组织TLR4信号通路的影响. 实用肝脏病杂志,2012,15(4):299-302. [8] 刘静,柳银兰,杨文君等.高脂高果糖饮食诱导NASH小鼠模型的建立和鉴定. 中华肝脏病杂志,2014,22(6):445-450. [9] Birkenfeld AL,Shulman GI. Nonalcoholic fatty liver disease,hepatic insulin resistance,and type 2 diabetes. Hepatology,2014,59(2):713-723. [10] Stanhope KL,Schwarz JM,Keim NL,et al. Consuming fructose-sweetened,not glucose-sweetened,beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest ,2009,119(5):1322-34. [11] Pollock NK,Bundy V,Kanto W,et al. Greater fructose consumption is associated with cardiometabolic risk markers and visceral adiposity in adolescents. J Nutr,2012,142(2):251-257. [12] Basaranoqlu M,Basaranoqlu G,Sabuncu T,et al. Fructose as a key player in the development of fatty liver disease.World J Gastroenterol,2013,19(8):1166-1172. [13] Vos MB, Lavine JE.Dietary fructose in nonalcoholic fatty liver disease.Hepatology,2013,57(6):2525-2531. [14] Jin R,Vos MB. Fructose and liver function-is this behind nonalcoholic liver disease Curr Opin Clin Nutr Metab Care,2015,18(5):490-495 [15] Nair S,Cope K,Risby T H,et al. Obesity and female gender increase breath ethanol concentration:potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J astroenterol,2001,96(4):1200-1204. [16] Baker SS,Baker RD,Liu WS,et al. Role of alcohol metabolism in non-alcoholic steatohepaitis. PLoS One,2010,5(3):e9570. [17] Lieber CS,Schmid R. The effect of ethanol on fatty acid metabolism;stimulation of hepatic fatty acid synthesis in vitro. J Clin Invest,1961,40:394-399. [18] Galli A,Price D,Crabb D .High-level expression of rat class I alcohol dehydrogenase is sufficient for ethanol-induced fat accumulation in transduced hela cells. Hepatology,1999,29(4): 1164-1170. [19] Rao RK,Seth A,Sheth P. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol, 2004,286(6):G881-G884. [20] Bode C,Bode JC.Activation of the innate immune system and?alcoholic liver disease: effects of ethanol per se?or enhancedintestinal translocation of bacterial toxins induced by ethanol Alcohol Clin Exp Res,2005,29(11 Suppl):166S-71S. |